𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

✍ Scribed by Paolo Angeli; Roberta Volpin; Giorgio Gerunda; Raffaella Craighero; Paola Roner; Roberto Merenda; Piero Amodio; Antonietta Sticca; Lorenza Caregaro; Alvise Maffei-Faccioli; Angelo Gatta


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
93 KB
Volume
29
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Midodrine, octreotide, albumin, and TIPS
✍ Florence Wong; Lavinia Pantea; Kenneth Sniderman πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 1 views

Hepatorenal syndrome (HRS) is a functional renal disorder complicating decompensated cirrhosis. Treatments to date, except liver transplantation, have been able to improve but not normalize renal function. The aim of this study was to determine the efficacy of transjugular intrahepatic portosystemic

Predictors of response to therapy with t
✍ AndrΓ© Nazar; Gustavo Henrique Pereira; MΓ³nica Guevara; Marta MartΓ­n-Llahi; Marie πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T

Impact of liver transplantation on the s
✍ Thomas D. Boyer; Arun J. Sanyal; Guadalupe Garcia-Tsao; Frederick Regenstein; Lo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 191 KB

The development of hepatorenal syndrome type 1 (HRS1) is associated with a poor prognosis. Liver transplantation improves this prognosis, but the degree of the improvement is unclear. Most patients receive vasoconstrictors such as terlipressin before transplantation, and this may affect the posttran

Acute effects of the oral administration
✍ Paolo Angeli; Roberta Volpin; Donatella Piovan; Andrea Bortoluzzi; Raffaella Cra πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

The effects of the acute administration of arterial vasoconstrictors on renal plasma flow (RPF) and urinary sodium excretion (UNaV) in cirrhotic patients with ascites with or without hepatorenal syndrome (HRS) are still controversial. As a consequence, vasoconstrictors are not actually used in the t